Royce & Associates’s HI-TECH PHARMACAL INC HITK Stock Holding History

Royce & Associates’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-700	Closed	-$30K	–	1499
2014 Q1	$30K	Hold	700	–	–	﹤0.01%	1395
2013 Q4	$30K	Hold	700	–	–	﹤0.01%	1409
2013 Q3	$30K	Sell	700 -1,684,925	-100%	-$64.5M	﹤0.01%	1419
2013 Q2	$56M	Buy	+1,685,625	New	+$56.1M	0.17%	146

Royce & Associates's HITK Position: Q2 2014 in Review

Royce & Associates sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 700 shares — an estimated $30K sold.

Royce & Associates first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $56M in Q2 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

Royce & Associates reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
Royce & Associates sold 700 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $30K.
Royce & Associates first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
Royce & Associates's HI-TECH PHARMACAL INC position peaked at $56M in Q2 2013.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.